Send us Feedback

HealthTronics (HTRN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
ENDP Makes Bullish Cross Above Critical Moving Average
Forbes  9 hrs ago  Comment 
In trading on Friday, shares of Endo Health Solutions Inc (NASD: ENDP) crossed above their 200 day moving average of $33.67, changing hands as high as $33.69 per share. Endo Health Solutions Inc shares are currently trading up about 0.9% on the...
Endo Health Solutions Inc. to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
PR Newswire  May 25  Comment 
CHADDS FORD, Pa., May 25, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will present a corporate overview at the Goldman Sachs 33rd Annual Global
Endo Health Solutions Inc. Announced as New Name for Endo Pharmaceuticals Holdings Inc.
PR Newswire  May 23  Comment 
CHADDS FORD, Pa., May 23, 2012 /PRNewswire-FirstCall/ -- Shareholders of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) voted today at its annual shareholders meeting to approve changing the company's name to Endo Health Solutions Inc. The name
Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
PR Newswire  May 1  Comment 
CHADDS FORD, Pa., May 1, 2012 /PRNewswire/ -- -- Total quarterly revenues of $691 million, increased 23 percent versus prior year; Driven by full quarter addition of AMS as well as Qualitest revenue growth of 8 percent. -- Adjusted diluted EPS of
Endo Acquires Johnson Matthey's Oxymorphone Patent
Benzinga  Mar 22  Comment 
Endo (Nasdaq: ENDP) announced today that it has acquired U.S. patent 7,851,482 B2 for oxymorphone hydrochloride, the key API in all formulations of OPANA, from Johnson Matthey plc. Johnson Matthey is a leading supplier of active pharmaceutical...
Endo (ENDP) Acquires Patent for Key API in All OPANA Formulations
StreetInsider.com  Mar 22  Comment 
Endo Pharma (ENDP) Amends CP for Generic LIDODERM; Highlights Growing Sector Support
StreetInsider.com  Mar 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Endo+Pharma+%28ENDP%29+Amends+CP+for+Generic+LIDODERM%3B+Highlights+Growing+Sector+Support/7263709.html for the full story.
Endo Files Amended Citizen Petition Seeking Public FDA Resolution of Several Safety and Efficacy Issues Prior to Approval of a Generic Formulation of LIDODERM
Benzinga  Mar 13  Comment 
Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it has filed an amendment to its Citizen Petition with the U.S. Food and Drug Administration (FDA) calling on FDA to publicly address numerous concerns raised by Endo and other experts about...
Mersana snaps up $270M cancer drug deal with Endo Pharma
FierceBiotech  Mar 7  Comment 
Mersana Therapeutics has scored its second major collaboration deal. Endo Pharmaceuticals ($ENDP) has tapped Mersana to create antibody-drug conjugates against an undisclosed cancer target. And like almost all biotech collaborations nowadays, this...
Mersana Therapeutics Enters Collaboration with Endo Pharmaceuticals to Develop Next-generation Antibody-drug Conjugates
Benzinga  Mar 7  Comment 




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/HealthTronics_(HTRN)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki